Pacira Net Debt from 2010 to 2026

PCRX Stock

USD 25.10 0.64 2.62%

Pacira BioSciences Net Debt yearly trend continues to be fairly stable with very little volatility. Net Debt is likely to outpace its year average in 2026. Net Debt is the total debt of Pacira BioSciences minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2009-12-31

Previous Quarter

330.9 M

Current Value

277.7 M

Quarterly Volatility

221.9 M

Credit Downgrade

Yuan Drop

Covid

Check Pacira BioSciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira BioSciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 95.1 M, Interest Expense of 15.3 M or Selling General Administrative of 147.4 M, as well as many indicators such as Price To Sales Ratio of 1.36, Dividend Yield of 0.0014 or PTB Ratio of 1.22. Pacira financial statements analysis is a perfect complement when working with Pacira BioSciences Valuation or Volatility modules.

Build AI portfolio with Pacira Stock

Check out the analysis of Pacira BioSciences Correlation against competitors.

For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences guide.

Latest Pacira BioSciences' Net Debt Growth Pattern

Below is the plot of the Net Debt of Pacira BioSciences over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Pacira BioSciences' Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pacira BioSciences' overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Pacira Net Debt Regression Statistics

	Arithmetic Mean	232,410,367
	Coefficient Of Variation	99.63
	Mean Deviation	200,768,153
	Median	222,371,000
	Standard Deviation	231,551,388
	Sample Variance	53616T
	Range	714.3M
	R-Value	0.86
	Mean Square Error	14973.8T
	R-Squared	0.74
	Slope	39,396,483
	Total Sum of Squares	857856.7T

Pacira Net Debt History

	2026	437.2 M
	2025	416.4 M
	2024	362.1 M
	2023	432.7 M
	2022	659.3 M
	2021	543.3 M
	2020	441.2 M

Other Fundumenentals of Pacira BioSciences

Net Debt To E B I T D A

Pacira BioSciences Net Debt component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Good Will	Long Term Debt Total	Capital Surpluse	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.97	0.47	0.93	0.33	0.75	0.88	0.96	0.41	0.98	0.95	0.67	0.95	0.67	0.97	-0.1	0.49	0.84	0.89	-0.03	0.73	0.89	0.61	0.83
Total Stockholder Equity	0.97		0.5	0.9	0.35	0.81	0.82	0.98	0.46	0.91	0.92	0.59	0.92	0.68	0.98	-0.03	0.43	0.82	0.89	-0.09	0.64	0.93	0.7	0.87
Current Deferred Revenue	0.47	0.5		0.52	-0.12	0.5	0.46	0.43	0.71	0.42	0.53	0.02	0.29	0.43	0.37	0.48	0.33	0.67	0.56	0.39	0.25	0.42	0.46	0.36
Net Debt	0.93	0.9	0.52		0.3	0.66	0.93	0.85	0.49	0.93	0.83	0.48	0.88	0.63	0.87	-0.02	0.64	0.85	0.86	0.23	0.57	0.85	0.47	0.71
Retained Earnings	0.33	0.35	-0.12	0.3		0.22	0.24	0.35	-0.36	0.29	0.12	0.17	0.49	-0.26	0.35	-0.52	0.06	-0.06	0.06	-0.25	0.08	0.55	0.31	0.46
Accounts Payable	0.75	0.81	0.5	0.66	0.22		0.6	0.84	0.46	0.67	0.79	0.35	0.71	0.41	0.81	0.05	0.11	0.71	0.71	-0.16	0.47	0.72	0.71	0.78
Long Term Debt	0.88	0.82	0.46	0.93	0.24	0.6		0.77	0.41	0.9	0.77	0.41	0.86	0.66	0.82	-0.09	0.74	0.87	0.89	0.15	0.52	0.79	0.42	0.61
Net Receivables	0.96	0.98	0.43	0.85	0.35	0.84	0.77		0.35	0.9	0.91	0.63	0.94	0.64	0.99	-0.17	0.3	0.77	0.84	-0.23	0.67	0.91	0.71	0.91
Short Term Investments	0.41	0.46	0.71	0.49	-0.36	0.46	0.41	0.35		0.36	0.54	0.11	0.14	0.61	0.33	0.8	0.28	0.72	0.65	0.57	0.21	0.37	0.45	0.31
Total Liab	0.98	0.91	0.42	0.93	0.29	0.67	0.9	0.9	0.36		0.93	0.72	0.94	0.63	0.92	-0.15	0.52	0.81	0.85	0.01	0.78	0.82	0.51	0.76
Total Current Assets	0.95	0.92	0.53	0.83	0.12	0.79	0.77	0.91	0.54	0.93		0.74	0.83	0.69	0.92	0.07	0.3	0.84	0.87	-0.05	0.8	0.78	0.69	0.81
Short Term Debt	0.67	0.59	0.02	0.48	0.17	0.35	0.41	0.63	0.11	0.72	0.74		0.62	0.4	0.65	-0.21	0.0	0.37	0.49	-0.26	0.9	0.48	0.41	0.61
Intangible Assets	0.95	0.92	0.29	0.88	0.49	0.71	0.86	0.94	0.14	0.94	0.83	0.62		0.54	0.96	-0.37	0.45	0.7	0.78	-0.23	0.65	0.88	0.56	0.82
Common Stock	0.67	0.68	0.43	0.63	-0.26	0.41	0.66	0.64	0.61	0.63	0.69	0.4	0.54		0.67	0.21	0.43	0.82	0.84	0.07	0.44	0.61	0.49	0.54
Property Plant Equipment	0.97	0.98	0.37	0.87	0.35	0.81	0.82	0.99	0.33	0.92	0.92	0.65	0.96	0.67		-0.17	0.37	0.78	0.86	-0.22	0.68	0.9	0.67	0.88
Net Tangible Assets	-0.1	-0.03	0.48	-0.02	-0.52	0.05	-0.09	-0.17	0.8	-0.15	0.07	-0.21	-0.37	0.21	-0.17		0.11	0.23	0.17	0.6	-0.14	-0.14	0.1	-0.2
Good Will	0.49	0.43	0.33	0.64	0.06	0.11	0.74	0.3	0.28	0.52	0.3	0.0	0.45	0.43	0.37	0.11		0.56	0.56	0.42	0.12	0.38	-0.1	0.06
Long Term Debt Total	0.84	0.82	0.67	0.85	-0.06	0.71	0.87	0.77	0.72	0.81	0.84	0.37	0.7	0.82	0.78	0.23	0.56		0.95	0.23	0.51	0.74	0.58	0.64
Capital Surpluse	0.89	0.89	0.56	0.86	0.06	0.71	0.89	0.84	0.65	0.85	0.87	0.49	0.78	0.84	0.86	0.17	0.56	0.95		0.09	0.59	0.83	0.63	0.73
Long Term Investments	-0.03	-0.09	0.39	0.23	-0.25	-0.16	0.15	-0.23	0.57	0.01	-0.05	-0.26	-0.23	0.07	-0.22	0.6	0.42	0.23	0.09		-0.14	-0.08	-0.3	-0.26
Short Long Term Debt	0.73	0.64	0.25	0.57	0.08	0.47	0.52	0.67	0.21	0.78	0.8	0.9	0.65	0.44	0.68	-0.14	0.12	0.51	0.59	-0.14		0.49	0.36	0.61
Net Invested Capital	0.89	0.93	0.42	0.85	0.55	0.72	0.79	0.91	0.37	0.82	0.78	0.48	0.88	0.61	0.9	-0.14	0.38	0.74	0.83	-0.08	0.49		0.73	0.9
Net Working Capital	0.61	0.7	0.46	0.47	0.31	0.71	0.42	0.71	0.45	0.51	0.69	0.41	0.56	0.49	0.67	0.1	-0.1	0.58	0.63	-0.3	0.36	0.73		0.82
Capital Stock	0.83	0.87	0.36	0.71	0.46	0.78	0.61	0.91	0.31	0.76	0.81	0.61	0.82	0.54	0.88	-0.2	0.06	0.64	0.73	-0.26	0.61	0.9	0.82

Click cells to compare fundamentals

About Pacira BioSciences Financial Statements

Pacira BioSciences investors use historical fundamental indicators, such as Pacira BioSciences' Net Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pacira BioSciences. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Net Debt	416.4 M	437.2 M
Net Debt To EBITDA	11.19	11.75

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

JBL	Jabil Circuit
MRK	Merck Company
AMGN	Amgen Inc

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences' price analysis, check to measure Pacira BioSciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences is operating at the current time. Most of Pacira BioSciences' value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences' price. Additionally, you may evaluate how the addition of Pacira BioSciences to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC

Pacira Net Debt from 2010 to 2026

Latest Pacira BioSciences' Net Debt Growth Pattern

Pacira Net Debt Regression Statistics

Pacira Net Debt History

Other Fundumenentals of Pacira BioSciences

Pacira BioSciences Net Debt component correlations

About Pacira BioSciences Financial Statements

Also Currently Popular

Additional Tools for Pacira Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY